G
Guobang Pharma Ltd
SSE:605507
Guobang Pharma Ltd
SSE:605507
Price:
26.39
CNY
-0.49%
Market Closed
Market Cap:
¥14.7B
Cash Flow Statement
Cash Flow Statement
Guobang Pharma Ltd
Guobang Pharma Ltd
Currency: CNY
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Cash Taxes Paid |
(35)
|
(47)
|
(66)
|
(54)
|
(37)
|
(1)
|
28
|
6
|
(32)
|
(19)
|
29
|
95
|
101
|
72
|
4
|
(28)
|
(48)
|
(55)
|
(78)
|
(99)
|
|
| Change in Working Capital |
(537)
|
(553)
|
(607)
|
(624)
|
(641)
|
(644)
|
(680)
|
(631)
|
(746)
|
(753)
|
(762)
|
(812)
|
(778)
|
(801)
|
(795)
|
(803)
|
(807)
|
(877)
|
(808)
|
(854)
|
|
| Cash from Operating Activities |
768
N/A
|
612
-20%
|
444
-27%
|
39
-91%
|
(176)
N/A
|
(126)
+29%
|
(177)
-41%
|
486
N/A
|
1 017
+109%
|
1 159
+14%
|
839
-28%
|
416
-50%
|
517
+24%
|
227
-56%
|
235
+3%
|
539
+129%
|
706
+31%
|
434
-39%
|
1 059
+144%
|
1 079
+2%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(520)
|
(542)
|
(553)
|
(518)
|
(448)
|
(371)
|
(399)
|
(471)
|
(803)
|
(883)
|
(917)
|
(882)
|
(748)
|
(722)
|
(579)
|
(476)
|
(419)
|
(333)
|
(404)
|
(482)
|
|
| Other Items |
155
|
103
|
137
|
(1 054)
|
(1 242)
|
(1 196)
|
(837)
|
164
|
391
|
558
|
433
|
642
|
387
|
305
|
(104)
|
(374)
|
(95)
|
(347)
|
(122)
|
(143)
|
|
| Cash from Investing Activities |
(365)
N/A
|
(439)
-20%
|
(416)
+5%
|
(1 572)
-278%
|
(1 690)
-7%
|
(1 568)
+7%
|
(1 236)
+21%
|
(307)
+75%
|
(412)
-34%
|
(326)
+21%
|
(485)
-49%
|
(240)
+50%
|
(361)
-50%
|
(418)
-16%
|
(684)
-64%
|
(850)
-24%
|
(514)
+40%
|
(680)
-32%
|
(526)
+23%
|
(625)
-19%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Debt |
80
|
(252)
|
(152)
|
(685)
|
(750)
|
(564)
|
(114)
|
521
|
495
|
558
|
249
|
87
|
308
|
323
|
210
|
161
|
(189)
|
(19)
|
(89)
|
(45)
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
(19)
|
(334)
|
(336)
|
(451)
|
(437)
|
(128)
|
(132)
|
(357)
|
(358)
|
(362)
|
(364)
|
(198)
|
(198)
|
(194)
|
(192)
|
(357)
|
(356)
|
|
| Other |
(354)
|
(312)
|
(151)
|
2 615
|
2 655
|
0
|
2 704
|
28
|
0
|
0
|
0
|
0
|
8
|
(19)
|
(91)
|
5
|
(3)
|
17
|
(14)
|
(110)
|
|
| Cash from Financing Activities |
(274)
N/A
|
(563)
-106%
|
(302)
+46%
|
1 911
N/A
|
1 571
-18%
|
1 764
+12%
|
2 139
+21%
|
112
-95%
|
367
+228%
|
427
+16%
|
(108)
N/A
|
(269)
-150%
|
(46)
+83%
|
(60)
-30%
|
(79)
-32%
|
(33)
+58%
|
(386)
-1 083%
|
(194)
+50%
|
(460)
-137%
|
(511)
-11%
|
|
| Change in Cash | |||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(33)
|
(31)
|
(44)
|
(38)
|
(10)
|
(14)
|
17
|
41
|
35
|
31
|
17
|
(4)
|
11
|
22
|
23
|
17
|
27
|
26
|
15
|
16
|
|
| Net Change in Cash |
96
N/A
|
(421)
N/A
|
(318)
+24%
|
339
N/A
|
(305)
N/A
|
57
N/A
|
743
+1 195%
|
333
-55%
|
1 007
+203%
|
1 291
+28%
|
264
-80%
|
(98)
N/A
|
120
N/A
|
(228)
N/A
|
(505)
-122%
|
(327)
+35%
|
(167)
+49%
|
(414)
-148%
|
89
N/A
|
(40)
N/A
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
248
N/A
|
70
-72%
|
(109)
N/A
|
(479)
-339%
|
(624)
-30%
|
(497)
+20%
|
(576)
-16%
|
15
N/A
|
214
+1 295%
|
276
+29%
|
(78)
N/A
|
(466)
-495%
|
(232)
+50%
|
(495)
-114%
|
(345)
+30%
|
62
N/A
|
287
+361%
|
101
-65%
|
656
+552%
|
597
-9%
|
|
Switch to:
Switch to:
See Also
Discover More
